Insider Trading Alert - DRE And CTIC Traded By Insiders

Friday, Feb. 26, 2016, 66 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $670.88 to $272,610,119.00.

Highlighted Stocks Traded by Insiders:

Duke Realty (DRE) - FREE Research Report

Shaw Jack R, who is Director at Duke Realty, sold 3,943 shares at $20.16 on Feb. 26, 2016. Following this transaction, the Director owned 7,096 shares meaning that the stake was reduced by 35.72% with the 3,943-share transaction.

The shares most recently traded at $20.87, up $0.71, or 3.4% since the insider transaction. Historical insider transactions for Duke Realty go as follows:

  • 4-Week # shares sold: 8,656
  • 12-Week # shares sold: 72,581
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 202,898

The average volume for Duke Realty has been 2.7 million shares per day over the past 30 days. Duke Realty has a market cap of $7.2 billion and is part of the financial sector and real estate industry. Shares are down 1.05% year-to-date as of the close of trading on Friday.

Duke Realty Corporation is an equity real estate investment trust. The firm invests in the real estate markets of the United States. It offers a single point of responsibility for all aspects of a project, including leasing, asset management, construction and development. The stock currently has a dividend yield of 3.45%. The company has a P/E ratio of 39.4. Currently, there are 5 analysts who rate Duke Realty a buy, 1 analyst rates it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DRE - FREE

TheStreet Quant Ratings rates Duke Realty as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, reasonable valuation levels, growth in earnings per share and relatively strong performance when compared with the S&P 500 during the past year. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Duke Realty Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Cell Therapeutics (CTIC) - FREE Research Report

Bianco James A, who is President and CEO at Cell Therapeutics, sold 10,000 shares at $0.63 on Feb. 26, 2016. Following this transaction, the President and CEO owned 2.1 million shares meaning that the stake was reduced by 0.47% with the 10,000-share transaction.

Singer Jack W, who is EVP, Chief Scientific Officer at Cell Therapeutics, sold 15,000 shares at $0.63 on Feb. 26, 2016. Following this transaction, the EVP, Chief Scientific Officer owned 1.0 million shares meaning that the stake was reduced by 1.42% with the 15,000-share transaction.

The shares most recently traded at $3.01, up $2.38, or 78.92% since the insider transaction. Historical insider transactions for Cell Therapeutics go as follows:

  • 4-Week # shares bought: 934,623
  • 4-Week # shares sold: 110,000
  • 12-Week # shares bought: 934,623
  • 12-Week # shares sold: 270,000
  • 24-Week # shares bought: 934,623
  • 24-Week # shares sold: 1.8 million

The average volume for Cell Therapeutics has been 3.7 million shares per day over the past 30 days. Cell Therapeutics has a market cap of $440.5 million and is part of the health care sector and drugs industry. Shares are up 53.93% year-to-date as of the close of trading on Tuesday.

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally.

Exclusive Offer: Get the latest Stock Analysis on CTIC - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Washington Federal (WAFD) - FREE Research Report

Smith Barbara, who is Director at Washington Federal, sold 0 shares at $0.00 on Feb. 26, 2016. Following this transaction, the Director owned 18,100 shares meaning that the stake was reduced by 0% with the 0-share transaction.

The shares most recently traded at $21.41, up $21.41, or 100% since the insider transaction. Historical insider transactions for Washington Federal go as follows:

  • 4-Week # shares bought: 8,000
  • 4-Week # shares sold: 2,150
  • 12-Week # shares bought: 8,000
  • 12-Week # shares sold: 2,150
  • 24-Week # shares bought: 8,000
  • 24-Week # shares sold: 12,150

The average volume for Washington Federal has been 904,900 shares per day over the past 30 days. Washington Federal has a market cap of $2.0 billion and is part of the financial sector and banking industry. Shares are down 9.4% year-to-date as of the close of trading on Friday.

Washington Federal, Inc. operates as the bank holding company for Washington Federal, National Association that provides financial services in the United States. The stock currently has a dividend yield of 2.62%. The company has a P/E ratio of 12.8. Currently, there are no analysts who rate Washington Federal a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WAFD - FREE

TheStreet Quant Ratings rates Washington Federal as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, expanding profit margins, good cash flow from operations and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Washington Federal Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

FCC Rocks Sinclair-Tribune Merger; Arconic Makes Perfect PE Sense -- ICYMI

FCC Rocks Sinclair-Tribune Merger; Arconic Makes Perfect PE Sense -- ICYMI

Bank of America Rips on Earnings Beat, But Analysts See Even More Gains Ahead

Bank of America Rips on Earnings Beat, But Analysts See Even More Gains Ahead

Will Micron Buy Back $10 Billion in Stock? Analyst Says Yes

Will Micron Buy Back $10 Billion in Stock? Analyst Says Yes

Stocks End Mixed as Dow Rises, S&P 500 and Nasdaq Slip

Stocks End Mixed as Dow Rises, S&P 500 and Nasdaq Slip

What to Watch When UnitedHealth Reports Results

What to Watch When UnitedHealth Reports Results